Biogen Inc. buy BMO Capital Markets
Start price
17.10.24
/
50%
€173.60
Target price
17.10.25
€212.52
Performance (%)
-29.64%
End price
18.10.25
€122.15
Summary
This prediction ended on 18.10.25 with a price of €122.15. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -29.64%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.533% | -2.533% | 58.092% |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $260.00 to $230.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten